Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-31 | New | $15,000,000 | $15,000,000 | Equity Only | 06b | SEC link |
| 2022-10-11 | New | $6,646,748 | $6,646,748 | Equity Only | 06b | SEC link |
| 2020-06-25 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Simon Allen | Director, Executive |
| Jason Aryeh | Director |
| Nathaniel Calloway | Director |
| Kenneth C. Cundy | Executive |
| Richard Cunningham | Director, Executive |
| Aron R. English | Director |
| Daniel George | Executive |
| Areta Kupchyk | Director |
| Joseph F. Lawler | Director |
| Kenneth Lin | Director |
| James R. Merchant | Executive |
| Karah Parschauer | Director |
| Bimal Shah | Director |